Edward D. Daugs,Eric J. Hagen,Jason A. Hanko,David H. Louks
申请号：
US11408609
公开号：
US08203019B2
申请日:
2006.04.20
申请国别(地区):
US
年份:
2012
代理人:
摘要：
The present invention provides crystalline solid and amorphous forms of (−)-halofenate. The crystalline solid forms may be used in various pharmaceutical compositions, and are particularly effective for the prevention and/or treatment of conditions associated with blood lipid deposition in a mammal, particularly those diseases related to Type 2 diabetes and hyperlipidemia. The invention also relates to a method for preventing or treating Type 2 diabetes and hyperlipidemia in a mammal comprising the step of administering a therapeutically effective amount of crystalline solid and amorphous forms of (−)-halofenate.
